Litcius/Paper detail

Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel

Xin Jin, Hu‐Ri Piao, Christophe Pannecouque, Erik De Clercq, Chunlin Zhuang, Fen‐Er Chen

2021European Journal of Medicinal Chemistry16 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryEtravirineNevirapineStereochemistryReverse transcriptaseSelectivityDocking (animal)Structure–activity relationshipMolecular modelSide chainEC50Nucleoside Reverse Transcriptase InhibitorReverse-transcriptase inhibitorLead compoundPyrimidineHuman immunodeficiency virus (HIV)In vitroBiochemistryRNAOrganic chemistryGeneViral loadNursingPolymerMedicineCatalysisAntiretroviral therapyFamily medicineHIV/AIDS drug development and treatmentSynthesis and Characterization of Heterocyclic CompoundsPneumocystis jirovecii pneumonia detection and treatment
Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel | Litcius